{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:07:29Z","timestamp":1771952849474,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.eplepsyres.2008.07.007","type":"journal-article","created":{"date-parts":[[2008,8,30]],"date-time":"2008-08-30T07:04:36Z","timestamp":1220079876000},"page":"70-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus"],"prefix":"10.1016","volume":"82","author":[{"given":"Jens P.","family":"Bankstahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2008.07.007_bib1","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neuropharm.2008.02.008","article-title":"Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain","volume":"54","author":"Bankstahl","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib2","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2967\/jnumed.108.051235","article-title":"Tariquidar-induced P-glycoprotein inhibition at the rat blood\u2013brain barrier studied with (R)-[11C]verapamil and PET","volume":"49","author":"Bankstahl","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0031-6997(25)00030-4","article-title":"Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo","volume":"41","author":"Borel","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-1211(03)00114-1","article-title":"Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats","volume":"55","author":"Brandt","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib5","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.0013-9580.2004.16904.x","article-title":"Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus","volume":"45","author":"Brandt","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00003088-199630020-00004","article-title":"Clinically significant drug interactions with cyclosporin. An update","volume":"30","author":"Campana","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0013-4694(82)90134-1","article-title":"Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures","volume":"53","author":"Cavalheiro","year":"1982","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib10","first-page":"199","article-title":"Epidemiology and clinical presentation of status epilepticus","volume":"97","author":"DeLorenzo","year":"2006","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib11","series-title":"Models of Seizures and Epilepsy","first-page":"415","article-title":"Kainate-induced status epilepticus: a chronic model of acquired epilepsy","author":"Dudek","year":"2006"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.2000.tb00283.x","article-title":"Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy","volume":"41","author":"Fujikawa","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1016\/j.eplepsyres.2008.07.007_bib14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yebeh.2005.08.003","article-title":"Prolonged seizures and cellular injury: understanding the connection","volume":"7","author":"Fujikawa","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-1211(01)00272-8","article-title":"Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy","volume":"46","author":"Glien","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib16","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib17","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib18","series-title":"Neuropharmacology Methods in Epilepsy Research","first-page":"95","article-title":"Experimental models of status epilepticus","author":"Goodman","year":"1998"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yebeh.2008.02.008","article-title":"Effective treatments of prolonged status epilepticus in developing rats","volume":"13","author":"Hasson","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1528-1167.2005.59204.x","article-title":"Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus","volume":"46","author":"Iannetti","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib22","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.eplepsyres.2008.07.007_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1528-1167.2006.00658.x","article-title":"The management of refractory status epilepticus: an update","volume":"47","author":"Lowenstein","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"L\u00f6scher","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1528-1167.2007.01093.x","article-title":"The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy","volume":"48","author":"L\u00f6scher","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"issue":"Suppl. 9","key":"10.1016\/j.eplepsyres.2008.07.007_bib27","first-page":"109","article-title":"Enhancement of antiepileptic drug treatment of experimental status epilepticus through inhibition of P-glycoprotein","volume":"44","author":"Mazarati","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib28","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-1211(99)00088-1","article-title":"A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat","volume":"38","author":"Nissinen","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib30","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1046\/j.1528-1157.2001.01901.x","article-title":"In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood\u2013brain barrier of rats","volume":"42","author":"Potschka","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib32","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1523\/JNEUROSCI.22-14-05833.2002","article-title":"Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance","volume":"22","author":"Rizzi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib34","unstructured":"Schmitt, F., Merschhemke, M., Dehnicke, C., Meencke, H., 2007. Status epilepticus with tonic seizures in non-lesional epilepsy: multidrug transporter inhibitor (verapamil) attenuates malignant treatment course. The 1st London Colloquium on Status Epilepticus, April 12\u201314, London, UK."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(78)90353-9","article-title":"Microinjection of kainic acid into the rat hippocampus","volume":"50","author":"Schwarcz","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1528-1157.2002.33101.x","article-title":"Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats","volume":"43","author":"Seegers","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0920-1211(02)00156-0","article-title":"Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy","volume":"51","author":"Seegers","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1528-1157.2003.42802.x","article-title":"Widespread upregulation of drug-resistance proteins in fatal human status epilepticus","volume":"44","author":"Sisodiya","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood\u2013brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"van Vliet","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.107.121178","article-title":"Region-specific overexpression of P-glycoprotein at the blood\u2013brain barrier affects brain uptake of phenytoin in epileptic rats","volume":"322","author":"van Vliet","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1369\/jhc.4A6451.2005","article-title":"Immunohistochemial localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables","volume":"53","author":"Volk","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2003.12.009","article-title":"Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats","volume":"58","author":"Volk","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib44","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib45","first-page":"217","article-title":"Status epilepticus and brain damage: pathology and pathophysiology","volume":"97","author":"Young","year":"2006","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib46","first-page":"183","article-title":"Status epilepticus and refractory status epilepticus: introductory and summary statements","volume":"97","author":"Young","year":"2006","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.eplepsyres.2008.07.007_bib47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s002210050759","article-title":"Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections","volume":"126","author":"Zhang","year":"1999","journal-title":"Exp. Brain Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121108002003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121108002003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:19:39Z","timestamp":1760275179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121108002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0920121108002003"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2008.07.007","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2008.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}